Visionary gerontologist and BioTime CEO Michael West shares his lessons learned

Big data. Everyone’s talking about it, but what exactly is it? And how can we best harness it?

CRISPR is the new kid on the block, but do ZFNs and TALENs still have a place?

Exablate Neuro combines MRI and focused ultrasound for non-invasive neurosurgery

In Punjab, a dengue fever hotline has evolved into a sophisticated forecasting tool

Jayasree K. Iyer, Executive Director of Access to Medicine Foundation, the Netherlands

A universal flu vaccine is possible – but we need bioinformatics to show us the way

We want faster translation of cell therapies, but is it worth sacrificing public trust?

Boston leads the drug discovery field, and the UK could soon follow suit

Virtual reality may be the distraction from pain that recovering patients need